Aarey Drugs Achieves 52-Week High Amid Broader Market Decline, Signaling Resilience in Small Caps
Aarey Drugs & Pharmaceuticals has achieved a new 52-week high of Rs. 79.09, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The stock has gained 10.21% over the last three days and is trading above key moving averages, showcasing a robust upward trend amid a declining broader market.
Aarey Drugs & Pharmaceuticals has made headlines today as its stock price reached a new 52-week high of Rs. 79.09, marking a significant milestone for the microcap company in the Pharmaceuticals & Biotechnology sector. The stock has shown impressive performance, outperforming its sector by 4.34% and achieving a consecutive gain over the last three days, with a total return of 10.21% during this period.Opening with a gain of 3.54%, Aarey Drugs touched an intraday high of Rs. 79.09, reflecting a 4.99% increase for the day. Notably, the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend in its price performance.
In the broader market context, the Sensex opened lower today at 82,151.07, down by 475.16 points, but is currently trading at 82,537.45. Despite the overall market's slight decline, small-cap stocks, including Aarey Drugs, are showing resilience, with the BSE Small Cap index gaining 0.15%. Over the past year, Aarey Drugs has delivered a return of 17.17%, contrasting with the Sensex's performance of -2.32%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
